What Researchers Did
Researchers reported a case of a 67-year-old male with laryngeal radionecrosis successfully treated with hyperbaric oxygen therapy after chemoradiotherapy for mesopharyngeal cancer.
What They Found
A 67-year-old male developed laryngeal radionecrosis, characterized by dyspnea and throat pain, 9 months after receiving chemoradiotherapy (71.4 Gy/38 Fr) for mesopharyngeal cancer. After initial conservative therapy failed, he received 20 sessions of hyperbaric oxygen therapy, which led to complete remission of his dyspnea and avoided laryngectomy.
What This Means for Canadian Patients
For Canadian patients experiencing laryngeal radionecrosis after cancer treatment, hyperbaric oxygen therapy could be considered as a non-surgical option to alleviate symptoms like dyspnea. This approach may help avoid more invasive procedures such as laryngectomy, improving quality of life for some individuals.
Canadian Relevance
This study has no direct Canadian connection as it is a case report from Japan.
Study Limitations
As a single case report, the findings of this study cannot be generalized to a broader patient population.